Skip to content
Search

Latest Stories

Professor Mahendra Patel joins UK Pharmacy Professional Leadership Advisory Board

The nine independent expert members of the UK Pharmacy Professional Leadership Advisory Board announced  

Professor Mahendra Patel OBE, CEO of the Oxford University Centre for Research Equity (CfRE), has been appointed as an independent expert member of the UK Pharmacy Professional Leadership Advisory Board.   

The newly established Board comprises nine independent expert members (IEMs) with outstanding leadership capabilities, who were appointed through open recruitment, ensuring a “broad, balanced, and diverse” representation.


Sir Hugh Taylor KCB, the Independent Chair of the Board, and the UK Chief Pharmaceutical Officers (CPhOs) – Andrew Evans (Wales), Cathy Harrison (Northern Ireland), Alison Strath (Scotland), and David Webb (England) – announced the appointment of IEMs in an open letter to the UK pharmacy professions.

“Bringing a wealth of experience and expertise, they will play a pivotal role in the Board’s work to deliver an exciting vision through supporting a new and dynamic phase of collaboration,” the CPhOs said.

As the CEO of CfRE, Professor Patel spearheads efforts aimed at addressing inequalities in healthcare.

Commenting on the appointment, Patel said: “It is a privilege to join this distinguished board of independent pharmacy experts, national pharmacy groups, and professional leadership bodies from across the UK.”

“The work we undertake must translate the UK Pharmacy Commission’s recommendations into tangible initiatives that elevate the pharmacy profession, driving excellence in practice and research to address health disparities and enhance outcomes for all.

“By fostering a culture of collaboration and inclusivity we will be paving the way for a progressive and aspirational future for the pharmacy profession.”

The CfRE stated that Patel’s appointment to the UK PPL Advisory Board has further strengthened its commitment to “advance the pharmacy profession and collaboration with key stakeholders to address health and care inequalities.” 

Pharmacy Professional Leadership Advisory Board

The establishment of this Board was the principal recommendation of the UK Commission on Pharmacy Professional Leadership’s report, published in February 2023.

The independent UK Commission report outlined that there is “an urgent need for the pharmacy professions to work collaboratively to deliver on their potential and, together, address a wide range of professional issues.”

Constituted as an independent public body, the Board aims to enable greater collaboration across the pharmacy professional leadership bodies (PLBs) and specialist professional groups (SPGs), which are its constituent members.

Over three years, the UK PPL Advisory Board, consisting of 21 members, will lead the delivery of the recommendations and ambitious vision set out by the UK Commission to:

  • Support and enable collaborative working.
  • Develop credible and authoritative leadership that is effective and speaks with one voice to the government, regulators, patients, employers and others in the public interest.
  • Contribute to the ambition of realising the future potential of pharmacy professionals in the NHS and other settings.

Sir Hugh Taylor was appointed as the Independent Chair for the Board in October 2023.

He is currently Chair of the Health Foundation, a Trustee of Cicely Saunders International, and Chief Negotiations Adviser (Voluntary Pricing and Access Scheme for branded medicines) at Department of Health and Social Care (DHSC).

On his appointment, Taylor said: "I am delighted and honoured to be taking on this role as Independent Chair.”

“Pharmacy is an integral and vital part of our health system. The aim of this Board is to lead and support collaboration across the professions in the UK, so that they can look to the future with ambition and confidence and realise their full potential. That is a hugely exciting mission - and one I very much look forward to supporting."

The Board members will meet four times a year. During the inaugural Board meeting on 23 April 2024, they will discuss the formation of a patient and public reference group, as well as a broader pharmacy stakeholder forum.

“These will feed advice and views into the Board meetings to ensure we’re in touch with the full range of pharmacy bodies, enabling us to involve even more colleagues in the work of the Board and ensure the greater transparency we’re keen to achieve,” Taylor said.

The Chair of the patient and public reference group will likely become a member of the Board once appointed.

Independent Expert Members of the Board are:

  1. Professor Mahendra Patel OBE, Director, Centre for Research Equity, University of Oxford
  2. Raymond Anderson, Director of Northern Pharmacies Ltd, Associate Consultant of Health and Social Care Leadership Centre, Belfast
  3. Laura Angus, Chief Pharmacy Officer/Director of Pharmacy and Medicines Optimisation, NHS Humber and North Yorkshire Integrated Care Board
  4. Rebecca Chamberlain, Standards Manager, General Optical Council
  5. Mildred Johnson, Chief Pharmacist/Clinical Director of Pharmacy and Medicines Optimisation, Maidstone & Tunbridge Wells NHS Trust
  6. Dr Berwyn Owen, Community Pharmacist, Fferyllfa Penygroes Pharmacy, Caernarfon
  7. Shilpa Shah, Chief Executive of Community Pharmacy North East London
  8. Panayiotis Sphikas, Head of Pharmacy Operations, University College London Hospitals NHS Foundation Trust
  9. Ellen Williams, Director of Regional Pharmacy Training Pharmacy Workforce Development South

Other Board members include

  1. Sir Hugh Taylor KCB: Independent Chair
  2. Nonyelum Anigbo, President, British Pharmaceutical Students' Association: Ex Officio Member – Specialist Professional Group
  3. Professor Claire Anderson, President, Royal Pharmaceutical Society: Ex Officio Member – Professional Leadership Body
  4. Dr Jeanette Dickson, Chair of Council, Academy of Medical Royal Colleges: Ex Officio Member – Professional Leadership Body
  5. Sheelin McKeagney, Chair of Pharmacy Forum Northern Ireland: Ex Officio Member – Professional Leadership Body
  6. Mohamed Rahman, President, UK Clinical Pharmacy Association: Ex Officio Member – Specialist Professional Group
  7. Karen Shuker, President, College of Mental Health Pharmacy : Ex Officio Member – Specialist Professional Group
  8. Nicola Stockmann, President, Association of Pharmacy Technicians UK: Ex Officio Member – Professional Leadership Body
  9. Dr Graham Stretch, President, Primary Care Pharmacy Association: Ex Officio Member – Specialist Professional Group
  10. Joseph Williams, Chair British Oncology Pharmacy Association: Ex Officio Member – Specialist Professional Group

Recruitment is underway for an IEM for Scotland, and the Ex Officio Member – Chair of Patient and Public Reference Group.

Additional details about the Board can be found here. 

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less